Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group

Affiliation auteurs!!!! Error affiliation !!!!
TitreBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group
Type de publicationJournal Article
Year of Publication2019
Auteursde Gramont A., Henriques J., Baruch B., Kim T.W, Martinez-Villacampa M., Gallego-Plazas J., Cervantes A., Shim K., Jonker D.J, Guerin-Meyer V., Mineur L., Banzi M., Dewdney A., T. Dejthevaporn S, Bloemendal H.J, Roth A.D, Thompson P., Moehler M., E. Aguilar A, Andre T.
JournalANNALS OF ONCOLOGY
Volume30
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534